Results 251 to 260 of about 49,575 (291)

Stereotactic body radiotherapy for unresectable cholangiocarcinoma

Radiotherapy and Oncology, 2010
To report outcomes of a single institution study of stereotactic body radiotherapy (SBRT) for unresectable cholangiocarcinoma. The dose-volume dependency of the observed gastrointestinal toxicity is explored.Twenty-seven patients with unresectable cholangiocarcinoma (n=26 Klatskin tumours and one intrahepatic cholangiocarcinoma (IHCC)) were treated by ...
Kopek, Neil, Holt, Marianne Ingerslev, Hansen, Anders Traberg, Høyer, Morten   +3 more
openaire   +3 more sources

Stereotactic Body Radiotherapy for Prostate Cancer

Clinical Oncology, 2015
The use of stereotactic body radiotherapy (SBRT) for localised prostate cancer is now supported by a substantial body of non-randomised data, with medium-term outcomes consistent with current standard radiotherapy. The ability to deliver profoundly hypofractionated treatment, combined with the relatively low α/β ratio of prostate cancer, may result in ...
D R, Henderson, A C, Tree, N J, van As
openaire   +2 more sources

Spinal Stereotactic Body Radiotherapy

2018
Patients treated for advanced cancer are often diagnosed with spinal metastases. During the course of their illness, most will be offered radiation treatment with external beam radiotherapy (EBRT). With improvement in systemic therapies and increasing cancer survivorship, local control and long-term pain control become significant therapeutic goals to ...
Annie Carbonneau, Arjun Sahgal, G. Laura Masucci   +2 more
openaire   +1 more source

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

The Cancer Journal, 2016
Hepatocellular carcinoma (HCC) is a leading cause of cancer death. Experience with radiotherapy for HCC is increasing. Stereotactic body radiotherapy allows the delivery of tumoricidal doses in 3 to 6 treatments to focal HCC with low rates of toxicity and excellent local control. Stereotactic body radiotherapy can be used to control disease in patients
Andrew J, McPartlin, Laura A, Dawson
openaire   +2 more sources

Prostate Stereotactic Body Radiotherapy — First UK Experience

Clinical Oncology, 2014
Stereotactic body radiotherapy (SBRT) combines image-guided radiotherapy with hypofractionation, both of which will probably result in improvements in patient outcomes in prostate cancer. Most clinical experience with this technique resides in North America.
Tree, A C, Ostler, Pete, Hoskin, P, Dankulchai, P, Nariyangadu, P, Hughes, R J, Wells, E, Taylor, H, Khoo, V S, van As, N J   +9 more
openaire   +3 more sources

[Stereotactic body radiotherapy (SBRT)].

Gan to kagaku ryoho. Cancer & chemotherapy, 2006
The techniques of three-dimensional conformal radiotherapy (3 D-CRT) and patient immobilization have recently been developed, enabling us to focus high doses on the target with relatively less irradiation of normal tissues. In radiotherapy for solitary lung tumors, the local control may be safely improved by delivering a higher dose at only the target ...
Yasushi, Nagata, Kenji, Takayama, Yukinori, Matsuo, Yoshiki, Norihisa, Takashi, Mizowaki, Masato, Sakamoto, Shinsuke, Yano, Yuichiro, Narita, Tokihiro, Yamamoto, Masahiro, Hiraoka   +9 more
openaire   +1 more source

Introduction to Stereotactic Body Radiotherapy

2014
Indications for Stereotactic Radiotherapy have expanded in recent years from intracranial treatment to extracranial, leading to the development of a thriving subspecialty within radiation oncology. The evidence base is growing exponentially. However there is still a lack of good quality prospective randomized clinical trial data.
Andrew M. Gaya, Anand Mahadevan
openaire   +1 more source

Stereotactic body radiotherapy in pancreatic adenocarcinoma

Hepatobiliary & Pancreatic Diseases International
Stereotactic body radiotherapy (SBRT) in pancreatic cancer allows high delivery of radiation doses on tumors without affecting surrounding tissue. This review aimed at the SBRT application in the treatment of pancreatic cancer.We retrieved articles published in MEDLINE/PubMed from January 2017 to December 2022.
openaire   +2 more sources

Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma

Journal of Medical Imaging and Radiation Oncology
AbstractIntroductionWe investigated the clinical outcomes of stereotactic body radiation therapy (SBRT) alone versus SBRT after incomplete transarterial chemoembolization (TACE) for a single recurrent hepatocellular carcinoma (HCC) smaller than 5 cm.MethodsWe retrospectively reviewed the medical records of patients who underwent SBRT for a single ...
Youngju Song, Jinhong Jung, Jin‐hong Park, So Yeon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Sang Min Yoon   +10 more
openaire   +2 more sources

Stereotactic Body Radiotherapy for Oligometastasis

2014
With tremendous strides in loco regional and systemic therapy many cancer patients present with limited metastatic disease. Just like the precedence of surgical metatstatectomy providing significant numbers of long term survivors, other evolving locoregional therapies can potentially achieve similar results, particularly when surgery is not an option ...
Nergiz R. Dagoglu, Anand Mahadevan
openaire   +1 more source